EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180 | -1.1% | 23,120 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $182 | +18.2% | 22,064 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $154 | -17.2% | 21,183 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $186 | -99.9% | 20,961 | -6.6% | 0.00% | -50.0% |
| Q3 2022 | $275,000 | +111.5% | 22,450 | +104.4% | 0.00% | +100.0% |
| Q2 2022 | $130,000 | -51.3% | 10,983 | -21.8% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -24.1% | 14,040 | +5.8% | 0.00% | -50.0% |
| Q4 2021 | $352,000 | -19.8% | 13,269 | +24.0% | 0.00% | 0.0% |
| Q3 2021 | $439,000 | -3.9% | 10,697 | +32.7% | 0.00% | -33.3% |
| Q2 2021 | $457,000 | +59.2% | 8,063 | +17.8% | 0.00% | +50.0% |
| Q1 2021 | $287,000 | -25.8% | 6,843 | +24.1% | 0.00% | 0.0% |
| Q4 2020 | $387,000 | +56.7% | 5,514 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $247,000 | -2.4% | 6,902 | -16.2% | 0.00% | 0.0% |
| Q4 2017 | $253,000 | +954.2% | 8,240 | +725.7% | 0.00% | – |
| Q2 2016 | $24,000 | – | 998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |